Influence of Neoadjuvant Immunotherapy-Chemotherapy on Perioperative Outcomes in Locally Advanced Esophageal Adenocarcinoma

CONCLUSION: The addition of immunotherapy to neoadjuvant chemotherapy for locally advanced esophageal adenocarcinoma does not appear to alter perioperative short-term outcomes significantly after esophagectomy.PMID:38530527 | DOI:10.1245/s10434-024-15186-z

Source: Ann Oncol - March 26, 2024 Category: Cancer & Oncology Authors: Yehonatan Nevo James Tankel Hedi Zhao Jaime Ramirez Jonathan Cools-Lartigue Carmen Muller Thierry Alcindor Lorenzo Ferri Source Type: research